Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 2 institutions in 1 country.
Rajesh ManiDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY, United States.
Mohamed H AbdelazizDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY, United States.
Eri OchiaiDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY, United States.
Qila SaDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY, United States.
Barbara A FoxDeaprtment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH, United States.
David J BzikDeaprtment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH, United States.
Yasuhiro SuzukiDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY, United States.
University of Kentucky · USDartmouth College · US
Funding
Cooperation of CD8+ T cells and phagocytes to eliminate Toxoplasma cystsR01AI095032 · NIAID · UNIVERSITY OF KENTUCKY · PI SUZUKI, YASUHIRO · 2012 to 2023
$4.1M
IFN-gamma production by microglia for prevention of toxoplasmic encephalitisR01AI078756 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI SUZUKI, YASUHIRO · 2008 to 2012
$1.8M
Metabolic basis for the persistence of dormant Toxoplasma gondii infectionR01AI172811 · NIAID · DARTMOUTH COLLEGE · PI DAVID J BZIK · 2023 to 2026
$1.6M
Intravacuolar network dense granule protein biology in chronic Toxoplasma infectionR21AI152687 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2020 to 2021
$451k
Effector molecules for IFN-gamma-mediated prevention of Toxoplasma proliferation in the brainR21AI134323 · NIAID · UNIVERSITY OF KENTUCKY · PI SUZUKI, YASUHIRO · 2017 to 2018
$421k
Gender-dependent innate IL-10 production as a key pathogenic factor to promote toxoplasmic encephalitisR21AI136821 · NIAID · UNIVERSITY OF KENTUCKY · PI SUZUKI, YASUHIRO · 2018 to 2019
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Dense granule protein 3 of · full record | OpenQuestion